ZXV-52062-38425
5 vaccinations
3 coded responses
52 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 190 / PA
- Registered
- 2021-03-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
55G-24882-01743
Child or adolescent in my care · Female · 2022-04-26
Timeline
-
2021-03-18
Dose 1 — Pfizer-BioNTech
-
2021-03-20
Registered in v-safe
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-04-01
-
2021-04-08
Dose 2 — Pfizer-BioNTech
- 2021-04-08
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-07-08
- 2021-10-07
-
2021-10-27
Dose 3 — Pfizer-BioNTech
- 2022-04-08
-
2022-04-26
Dose 4 — Pfizer-BioNTech
- 2022-04-26
- 2022-04-27
-
2022-04-28
Survey response — days 1–6 daily, dose 4MedDRA: Rhinorrhoea, Upper-airway cough syndrome — Feeling: Fair · Fever · Fatigue or tirednessFree text: Running nose & post nasal drip into back of throatMedDRA releases: 2024-11 · check-in free text available
- 2022-04-29
- 2022-04-30
- 2022-05-01
- 2022-05-02
- 2022-05-03
- 2022-05-10
- 2022-05-18
- 2022-05-24
- 2022-05-31
- 2022-06-07
-
2022-07-26
Survey response — 3 months, dose 4MedDRA: Chest discomfort, Chills, Fatigue, Laboratory test abnormal, Mobility decreased, Pain, Patient isolation, Pre-existing disease, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Tested positive 7/15. Began Paxlovid next day. Was in bed with fever, chills, aches, chronic cough & tight lungs for 5 days, until symptoms began to dissipate. Isolated myself from two family members, ages 15 & 63. We wore KN95s. They remained well.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-26
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-07-27
Call successfulCompleted over the phone
-
2022-10-10
Dose 5 — Pfizer-BioNTech
- 2022-10-10
-
2022-10-11
Survey response — days 1–6 daily, dose 5MedDRA: Emergency care, Hypoaesthesia, Hypoaesthesia eye, Visual impairment — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Severe visual disturbance lasting 20-30 min; numbness around eyes, through temples and in head around ears. Currently in ER to rule out TIA.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-11
Report sent to call center — days 1–6 daily, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-10-12
- 2022-10-12
-
2022-10-12
Call successfulCompleted over the phone
- 2022-10-13
- 2022-10-14
- 2022-10-15
- 2022-10-16
- 2022-10-17
- 2022-10-24
- 2022-10-31
- 2022-11-07
- 2022-11-14
- 2022-11-21
- 2023-01-09
- 2023-04-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech | |
| 2 | 2021-04-08 | Pfizer-BioNTech | |
| 3 | 2021-10-27 | Pfizer-BioNTech | No |
| 4 | 2022-04-26 | Pfizer-BioNTech | No |
| 5 | 2022-10-10 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 2
Free text
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Running nose & post nasal drip into back of throat
Release 12 — 3 months, dose 4
Symptoms: Tested positive 7/15. Began Paxlovid next day. Was in bed with fever, chills, aches, chronic cough & tight lungs for 5 days, until symptoms began to dissipate. Isolated myself from two family members, ages 15 & 63. We wore KN95s. They remained well. cut off by CDC
Release 12 — days 1–6 daily, dose 5
Systemic reaction (other): Severe visual disturbance lasting 20-30 min; numbness around eyes, through temples and in head around ears. Currently in ER to rule out TIA.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest discomfort | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Laboratory test abnormal | · | · | ✓ |
| SD | Mobility decreased | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Patient isolation | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SRO | Emergency care | · | · | ✓ |
| SRO | Hypoaesthesia | · | · | ✓ |
| SRO | Hypoaesthesia eye | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Upper-airway cough syndrome | · | · | ✓ |
| SRO | Visual impairment | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release